CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L

References

• Hu JX, Zhao CF, Chen WB, Liu QC, Li QW, Lin YY, Gao F. Pancreatic cancer: a review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27(27):4298–15. doi:10.3748/wjg.v27.i27.4298.
   PubMed Web of Science ®Google Scholar
• Bakasa W, Viriri S. 2021. Pancreatic cancer survival prediction: a survey of the State-of-the-art. Comput Math Methods Med. 2021:1188414. 10.1155/2021/1188414.
   PubMed Web of Science ®Google Scholar
• Ettrich TJ, Seufferlein T. Systemic therapy for metastatic pancreatic cancer. Curr Treat Options Oncol. 2021;22(11):106. doi:10.1007/s11864-021-00895-4.
   PubMed Web of Science ®Google Scholar
• Tonini V, Zanni M. Pancreatic cancer in 2021: what you need to know to win. World J Gastroenterol. 2021;27(35):5851–5889. doi:10.3748/wjg.v27.i35.5851.
   PubMed Web of Science ®Google Scholar
• Traub B, Link KH, Kornmann M. 2021. Curing pancreatic cancer. Semin Cancer Biol. 76:232–246. 10.1016/j.semcancer.2021.05.030.
   PubMed Web of Science ®Google Scholar
• Chandra AJ, Lee SCS, Grunert U. 2019. Melanopsin and calbindin immunoreactivity in the inner retina of humans and marmosets. Vis Neurosci. 36:E009. 10.1017/S0952523819000087.
   PubMed Web of Science ®Google Scholar
• Blum W, Schwaller B. Calretinin is essential for mesothelioma cell growth/survival in vitro: a potential new target for malignant mesothelioma therapy? Int J Cancer. 2013;133(9):2077–2088. doi:10.1002/ijc.28218.
   PubMed Web of Science ®Google Scholar
• Le Large TY, Mantini G, Meijer LL, Pham TV, Funel N, van Grieken NC, Kok B, Knol J, van Laarhoven HW, Piersma SR, et al. 2020. Microdissected pancreatic cancer proteomes reveal tumor heterogeneity and therapeutic targets. JCI Insight. 5(15):e138290. doi:10.1172/jci.insight.138290.
   PubMed Web of Science ®Google Scholar
• Zeng S, Pottler M, Lan B, Grutzmann R, Pilarsky C, Yang H. Chemoresistance in pancreatic cancer. Int J Mol Sci. 2019;20(18):4504. doi:10.3390/ijms20184504.
   PubMed Web of Science ®Google Scholar
• Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331(6024):1559–1564. doi:10.1126/science.1203543.
   PubMed Web of Science ®Google Scholar
• Chu H, Zhao Q, Shan Y, Zhang S, Sui Z, Li X, Fang F, Zhao B, Zhong S, Liang Z, et al. 2022. All-ion monitoring-directed low-abundance protein quantification reveals CALB2 as a key promoter in hepatocellular carcinoma metastasis. Anal Chem. 94:6102–6111. 10.1021/acs.analchem.1c03562.
   PubMed Web of Science ®Google Scholar
• Gong F, Miller KM. 2019. Histone methylation and the DNA damage response. Mutat Res Rev Mutat Res. 780:37–47. 10.1016/j.mrrev.2017.09.003.
   PubMed Web of Science ®Google Scholar
• Collins BE, Greer CB, Coleman BC, Sweatt JD. Histone H3 lysine K4 methylation and its role in learning and memory. Epigenetics & Chromatin. 2019;12(1):7. doi:10.1186/s13072-018-0251-8.
   PubMedGoogle Scholar
• Hughes AL, Kelley JR, Klose RJ. Understanding the interplay between CpG island-associated gene promoters and H3K4 methylation. Biochim Biophys Acta Gene Regul Mech. 2020;1863(8):194567. doi:10.1016/j.bbagrm.2020.194567.
   PubMed Web of Science ®Google Scholar
• Niu Q, Song Z, Tang K, Chen L, Wang L, Ban T, Guo Z, Kim C, Zhang H, Duan CG, et al. 2021. A histone H3K4me1-specific binding protein is required for siRNA accumulation and DNA methylation at a subset of loci targeted by RNA-directed DNA methylation. Nat Commun. 12(1):3367. doi:10.1038/s41467-021-23637-4.
   PubMed Web of Science ®Google Scholar
• Froimchuk E, Jang Y, Ge K. Histone H3 lysine 4 methyltransferase KMT2D. Gene. 2017;627:337–342. doi:10.1016/j.gene.2017.06.056.
   PubMed Web of Science ®Google Scholar
• Ernst P, Vakoc CR. WRAD: enabler of the SET1-family of H3K4 methyltransferases. Brief Funct Genomics. 2012;11(3):217–226. doi:10.1093/bfgp/els017.
   PubMed Web of Science ®Google Scholar
• Li SS, Jiang WL, Xiao WQ, Li K, Zhang YF, Guo XY, Dai YQ, Zhao QY, Jiang MJ, Lu ZJ, et al. 2019. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma. World J Gastrointest Oncol. 11(8):599–621. doi:10.4251/wjgo.v11.i8.599.
   PubMed Web of Science ®Google Scholar
• Wu YJ, Ko BS, Liang SM, Lu YJ, Jan YJ, Jiang SS, Shyue SK, Chen L, Liou JY. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma. Cell Death & Disease. 2019;10(6):408. doi:10.1038/s41419-019-1651-9.
   PubMedGoogle Scholar
• Zeng K, Wu Y, Wang C, Wang S, Sun H, Zou R, Sun G, Song H, Liu W, Sun N, et al. 2020. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription. Cancer Sci. 111(6):2062–2077. doi:10.1111/cas.14413.
   PubMed Web of Science ®Google Scholar
• Rocha-Viegas L, Silbermins M, Ogara MF, Pellegrini JM, Nunez SY, Garcia VE, Vicent GP, Pecci A. Glucocorticoids uncover a critical role for ASH2L on BCL-X expression regulation in leukemia cells. Biochim Biophys Acta Gene Regul Mech. 2020;1863(1):194475. doi:10.1016/j.bbagrm.2019.194475.
   PubMed Web of Science ®Google Scholar
• Lujan DA, Ochoa JL, Hartley RS. 2018. Cold-inducible RNA binding protein in cancer and inflammation. Wiley Interdiscip Rev RNA. 9(2). doi:10.1002/wrna.1462.
   PubMed Web of Science ®Google Scholar
• Sommer G, Heise T. Role of the RNA-binding protein La in cancer pathobiology. RNA Biol. 2021;18(2):218–236. doi:10.1080/15476286.2020.1792677.
   PubMed Web of Science ®Google Scholar
• Feng L, Jing F, Qin X, Zhou L, Ning Y, Hou J, Kong W, Zhu Y. 2022. Cleavage stimulation factor subunit 2: function across cancers and potential target for chemotherapeutic drugs. Front Pharmacol. 13:852469. 10.3389/fphar.2022.852469.
   PubMed Web of Science ®Google Scholar
• Chen X, Zhang JX, Luo JH, Wu S, Yuan GJ, Ma NF, Feng Y, Cai MY, Chen RX, Lu J, et al. 2018. CSTF2-Induced Shortening of the RAC1 3′UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder. Cancer Res. 78(20):5848–5862. doi:10.1158/0008-5472.CAN-18-0822.
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen D, Wang Q, Xu Y, Huang X, Haglund F, Su H. 2021. Immunological classification of pancreatic carcinomas to identify immune index and provide a strategy for patient stratification. Front Immunol. 12:719105. 10.3389/fimmu.2021.719105.
   PubMed Web of Science ®Google Scholar
• Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L. 2019. Ribophorin II potentiates P-glycoprotein- and ABCG2-mediated multidrug resistance via activating ERK pathway in gastric cancer. Int J Biol Macromol. 128:574–582. 10.1016/j.ijbiomac.2019.01.195.
   PubMed Web of Science ®Google Scholar
• Li D, Cai L, Meng R, Feng Z, Xu Q. METTL3 modulates osteoclast differentiation and function by controlling RNA stability and nuclear export. Int J Mol Sci. 2020;21(5):1660. doi:10.3390/ijms21051660.
   PubMed Web of Science ®Google Scholar
• Kimura H. Histone modifications for human epigenome analysis. J Hum Genet. 2013;58(7):439–445. doi:10.1038/jhg.2013.66.
   PubMed Web of Science ®Google Scholar
• Fincham REA, Delvecchio FR, Goulart MR, Yeong JPS, Kocher HM. Natural killer cells in pancreatic cancer stroma. World J Gastroenterol. 2021;27(24):3483–3501. doi:10.3748/wjg.v27.i24.3483.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu F, Xue Q, Weng X, Xu F. Metastatic pancreatic cancer: mechanisms and detection (Review). Oncol Rep. 2021;46(5):231. doi:10.3892/or.2021.8182.
   PubMed Web of Science ®Google Scholar
• Lu S, Zhao R, Shen J, Zhang Y, Shi J, Xu C, Chen J, Lin R, Han W, Luo D. 2020. Integrated bioinformatics analysis to screen hub genes in the lymph node metastasis of thyroid cancer. Oncol Lett. 19:1375–1383. 10.3892/ol.2019.11188.
   PubMed Web of Science ®Google Scholar
• Li W, Wu L, Jia H, Lin Z, Zhong R, Li Y, Jiang C, Liu S, Zhou X, Zhang E. The low-complexity domains of the KMT2D protein regulate histone monomethylation transcription to facilitate pancreatic cancer progression. Cell Mol Biol Lett. 2021;26(1):45. doi:10.1186/s11658-021-00292-7.
   PubMed Web of Science ®Google Scholar
• Harris JC, Martinez JM, Grozdanov PN, Bergeson SE, Grammas P, MacDonald CC, Yan W. The Cstf2t Polyadenylation gene plays a sex-specific role in learning behaviors in mice. PLos One. 2016;11(11):e0165976. doi:10.1371/journal.pone.0165976.
   PubMed Web of Science ®Google Scholar
• Akman HB, Oyken M, Tuncer T, Can T, Erson-Bensan AE. 2015. 3‘UTR shortening and EGF signaling: implications for breast cancer. Hum Mol Genet. 24:6910–6920. 10.1093/hmg/ddv391.
   PubMed Web of Science ®Google Scholar
• Zhang MH, Liu J. Cleavage stimulation factor 2 promotes malignant progression of liver hepatocellular carcinoma by activating phosphatidylinositol 3′-kinase/protein kinase B/mammalian target of rapamycin pathway. Bioengineered. 2022;13(4):10047–10060. doi:10.1080/21655979.2022.2063100.
   PubMed Web of Science ®Google Scholar